BLTEBelite Bio, Inc

$7B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$16M

Net Income

-$14M

EPS (Diluted)

$-0.44

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$164M

Total Liabilities

$6M

Stockholders' Equity

$158M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$16M	-$8M	-86.3%
Net Income	-$14M	-$8M	-81.4%

BLTE Q1 2025 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena